Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
The Oncologist|April 5, 2007
Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I diseaseHeather Wakelee, Sarita Dubey, David GandaraJournal of Thoracic Disease|October 29, 2013
The continuing role of chemotherapy for advanced non-small cell lung cancer in the targeted therapy eraZarnie Lwin, Jonathan W Riess, David GandaraClinical Lung Cancer|August 8, 2007
Dual inhibition: combining epidermal growth factor-targeted therapies in non-small-cell lung cancerCheryl Ho, Angela Davies, Philip Mack, et al.Lung Cancer (Amsterdam, Netherlands)|December 14, 2002
Adjuvant and neoadjuvant treatments for NSCLCEverett E Vokes, Hak Choy, David Gandara, et al.Oncology Reports|April 6, 2006
Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatmentAgnes Juhasz, Aikaterini Vassilakos, Helen K Chew, et al.Seminars in Oncology|July 15, 2005
Southwest Oncology Group: two decades of experience in non-small cell lung cancerAndrew T Turrisi, John Crowley, Kathy Albain, et al.Clinical Lung Cancer|November 9, 2019
CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non-small-cell Lung CancerBenjamin Owen, David Gandara, Karen Kelly, et al.Critical Reviews in Oncology/Hematology|May 26, 2004
Enhancement of radiotherapy with DNA topoisomerase I-targeted drugsAllan Y Chen, Rachel Chou, Shyh-Jen Shih, et al.Clinical Lung Cancer|April 23, 2005
Computer-assisted image analysis of bronchioloalveolar carcinomaDerick Lau, Anthony Seibert, David Gandara, et al.Cancer Investigation|August 29, 2002
Premedication strategy for weekly paclitaxelJustin Quock, Gilland Dea, Michael Tanaka, et al.Pageof 8